Literature DB >> 8335695

A 60-kD protein mediates the binding of transforming growth factor-beta to cell surface and extracellular matrix proteoglycans.

R Bützow1, D Fukushima, D R Twardzik, E Ruoslahti.   

Abstract

The biological activity of many cytokines is regulated by binding proteins present at the cell surface, in extracellular matrices or in soluble phase. We describe here a TGF-beta binding protein that is both an extracellular matrix and a cell surface protein. When intact extracellular matrices of HEP-G2 cells were affinity cross-linked with 125I-TGF-beta 1, two major binding components were seen: a 250-kD, proteoglycan-like molecule, presumed to be betaglycan, and a 60-kD protein. The 60-kD TGF-beta-binding protein was also present at the cell surface. It could be released from the cell surface by treating cells with high salt, heparin, chondroitin sulfate, heparitinase, or chondroitinase, indicating that it is bound to heparan sulfate and chondroitin sulfate proteoglycans. The 60-kD protein bound TGF-beta 1 with an apparent dissociation constant of 1.6 nM, and there were 30,000 binding sites per cell at the cell surface. In addition to the HEP-G2 cells and another hepatoma cell line, the 60-kD protein was also found in a human colon carcinoma (HT-29) cell line but not in rat kidney (NRK-49F) or human fibroblast (HUT-12) cell lines. The 60-kD protein could be extracted from cells containing it and transferred to the surface of previously negative cells. The 60-kD protein may serve to regulate the binding of TGF-beta to its signal transducing receptors by targeting TGF-beta to appropriate locations in the microenvironment of cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8335695      PMCID: PMC2119664          DOI: 10.1083/jcb.122.3.721

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  43 in total

1.  Reversible inhibition of normal human prokeratinocyte proliferation by type beta transforming growth factor-growth inhibitor in serum-free medium.

Authors:  G D Shipley; M R Pittelkow; J J Wille; R E Scott; H L Moses
Journal:  Cancer Res       Date:  1986-04       Impact factor: 12.701

2.  Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro.

Authors:  A B Roberts; M B Sporn; R K Assoian; J M Smith; N S Roche; L M Wakefield; U I Heine; L A Liotta; V Falanga; J H Kehrl
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

3.  Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix.

Authors:  R A Ignotz; J Massagué
Journal:  J Biol Chem       Date:  1986-03-25       Impact factor: 5.157

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Expression of transfected mutant beta-actin genes: alterations of cell morphology and evidence for autoregulation in actin pools.

Authors:  J Leavitt; S Y Ng; U Aebi; M Varma; G Latter; S Burbeck; L Kedes; P Gunning
Journal:  Mol Cell Biol       Date:  1987-07       Impact factor: 4.272

6.  Purification and partial characterization of small proteoglycans I and II, bone sialoproteins I and II, and osteonectin from the mineral compartment of developing human bone.

Authors:  L W Fisher; G R Hawkins; N Tuross; J D Termine
Journal:  J Biol Chem       Date:  1987-07-15       Impact factor: 5.157

7.  Fibronectin-associated transforming growth factor.

Authors:  R A Fava; D B McClure
Journal:  J Cell Physiol       Date:  1987-05       Impact factor: 6.384

8.  Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death.

Authors:  A B Kulkarni; C G Huh; D Becker; A Geiser; M Lyght; K C Flanders; A B Roberts; M B Sporn; J M Ward; S Karlsson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-15       Impact factor: 11.205

9.  Type beta transforming growth factor is the primary differentiation-inducing serum factor for normal human bronchial epithelial cells.

Authors:  T Masui; L M Wakefield; J F Lechner; M A LaVeck; M B Sporn; C C Harris
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

10.  Evidence that transforming growth factor-beta is a hormonally regulated negative growth factor in human breast cancer cells.

Authors:  C Knabbe; M E Lippman; L M Wakefield; K C Flanders; A Kasid; R Derynck; R B Dickson
Journal:  Cell       Date:  1987-02-13       Impact factor: 41.582

View more
  10 in total

1.  Localisation of extracellular matrix components in the embryonic human notochord and axial mesenchyme.

Authors:  W Götz; R Osmers; R Herken
Journal:  J Anat       Date:  1995-02       Impact factor: 2.610

2.  Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta.

Authors:  A Hildebrand; M Romarís; L M Rasmussen; D Heinegård; D R Twardzik; W A Border; E Ruoslahti
Journal:  Biochem J       Date:  1994-09-01       Impact factor: 3.857

Review 3.  Extracellular matrix and growth factors during heart growth.

Authors:  S Corda; J L Samuel; L Rappaport
Journal:  Heart Fail Rev       Date:  2000-06       Impact factor: 4.214

4.  Characterization of a human hepatoma cell line with acquired resistance to growth inhibition by transforming growth factor beta 1 (TGF-beta 1).

Authors:  K Hasegawa; Z Wang; M Inagaki; B I Carr
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-01       Impact factor: 2.416

5.  Collagen type IV and Perlecan exhibit dynamic localization in the Allantoic Core Domain, a putative stem cell niche in the murine allantois.

Authors:  Maria M Mikedis; Karen M Downs
Journal:  Dev Dyn       Date:  2009-12       Impact factor: 3.780

6.  Basal lamina and other extracellular matrix produced by bovine granulosa cells in anchorage-independent culture.

Authors:  H F Rodgers; T C Lavranos; C A Vella; R J Rodgers
Journal:  Cell Tissue Res       Date:  1995-12       Impact factor: 5.249

7.  Transforming growth factor beta depletion is the primary determinant of Smad signaling kinetics.

Authors:  David C Clarke; Meredith L Brown; Richard A Erickson; Yigong Shi; Xuedong Liu
Journal:  Mol Cell Biol       Date:  2009-02-17       Impact factor: 4.272

8.  Rapid up-regulation of alpha4 integrin-mediated leukocyte adhesion by transforming growth factor-beta1.

Authors:  Rubén A Bartolomé; Francisco Sanz-Rodríguez; Mar M Robledo; Andrés Hidalgo; Joaquin Teixidó
Journal:  Mol Biol Cell       Date:  2003-01       Impact factor: 4.138

9.  Plasmin cleaves betaglycan and releases a 60 kDa transforming growth factor-beta complex from the cell surface.

Authors:  J Lamarre; J Vasudevan; S L Gonias
Journal:  Biochem J       Date:  1994-08-15       Impact factor: 3.857

10.  Soluble and membrane-bound TGF-β-mediated regulation of intratumoral T cell differentiation and function in B-cell non-Hodgkin lymphoma.

Authors:  Zhi-Zhang Yang; Deanna M Grote; Steven C Ziesmer; Bing Xiu; Nicole R Yates; Frank J Secreto; Lucy S Hodge; Thomas E Witzig; Anne J Novak; Stephen M Ansell
Journal:  PLoS One       Date:  2013-03-15       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.